Archive · 3 Oct 2025
Rubicon Research IPO: Price Band Set, Key Dates Announced
Rubicon Research, a company that makes medicines, is selling shares to the public to get money.
This is called an IPO, and they aim to raise ₹1,377.50 crore by selling shares at a price between ₹461 and ₹485 each.
The money will help them pay off debts and grow their business.
The company focuses on making medicines for markets like the US, where they already have many approved products.
The IPO will be open from October 9 to October 13, and the shares are expected to start trading on October 16.
Rubicon Research is launching an IPO to raise ₹1,377.50 crore.
The IPO price band is set at ₹461–485 per share.
The IPO will open on October 9 and close on October 13.
Funds will be used for debt repayment, acquisitions, and corporate purposes.
The company focuses on pharmaceutical formulations targeting regulated markets, particularly in the United States.
- Who
- Rubicon Research, a pharmaceutical formulations company.
- What
- Is launching an initial public offering (IPO).
- When
- The IPO opens October 9 and closes October 13; shares expected to list October 16.
- Where
- India.
- Why
- To raise funds for debt repayment, acquisitions, and general corporate purposes.
Shareholder concerns
Company Objectives
Valuation
Shareholder concerns
N/A
Company Objectives
Raise capital to reduce debt and funding the company growth plans.
- IPO Size
- ₹1,377.50 crore
- Price Band
- ₹461–485 per share
- Opening Date
- October 9
- Closing Date
- October 13
- Listing Date (Tentative)
- October 16
- Use of Proceeds
- Debt repayment, funding inorganic growth, and corporate purposes
- Company Focus
- Pharmaceutical formulations targeting regulated markets
